KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Cvs Health (CVS) Interest Expenses (2016 - 2025)

Cvs Health (CVS) has disclosed Interest Expenses for 14 consecutive years, with $787.0 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Interest Expenses rose 3.83% year-over-year to $787.0 million, compared with a TTM value of $3.1 billion through Dec 2025, up 5.44%, and an annual FY2025 reading of $3.1 billion, up 5.44% over the prior year.
  • Interest Expenses was $787.0 million for Q4 2025 at Cvs Health, roughly flat from $784.0 million in the prior quarter.
  • Across five years, Interest Expenses topped out at $787.0 million in Q4 2025 and bottomed at $552.0 million in Q4 2022.
  • Average Interest Expenses over 5 years is $676.2 million, with a median of $688.0 million recorded in 2023.
  • The sharpest move saw Interest Expenses fell 17.65% in 2021, then grew 25.0% in 2023.
  • Year by year, Interest Expenses stood at $608.0 million in 2021, then fell by 9.21% to $552.0 million in 2022, then increased by 25.0% to $690.0 million in 2023, then grew by 9.86% to $758.0 million in 2024, then increased by 3.83% to $787.0 million in 2025.
  • Business Quant data shows Interest Expenses for CVS at $787.0 million in Q4 2025, $784.0 million in Q3 2025, and $763.0 million in Q2 2025.